Digg It - Internet and Businesses Online

One of the reasons that Ezines and all online newsletters do so well

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

is because people are upset at the trade journals, which seem to ha

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

e so many filler pages of worthless content that many of the subscri

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ers are no longer interested. You have probably seen in many indust

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

y trade journals where the articles are somewhat irrelevant to the i

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

dustry yet in the first paragraph and the last paragraph it appears

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

hat the articles have been modified in order to get the classificati

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

n of that particular industry sector.

It doesn't take a rocket scie

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

tist or someone in an industry to recognize that these articles are

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

asically BS and merely public relations pieces in order to sell them

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

something and therefore they flip through theses trade journals very

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

quickly without reading them. Further this hurts the advertisers be

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ause the subscriber is also flipping past the advertising.

If a tra

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

e journal has too few articles in it and the magazine is not very th

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ck people do not value it, but too much filler and people no longer

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ave any value added. This same problem applies to Ezine Publishing

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

nd we see all too often that there are articles, which are completel

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

worthless to the subject matter of the Ezine or are so basic that t

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ey are irrelevant to the reader. Therefore, Ezine Publishers need to

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

be very careful of such Filler Content. Please consider this in 2006

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/63359/diggit-Ezine-Publishing-Be-Careful-of-Filler-Content.html">Ezine Publishing; Be Careful of Filler Content</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/63359/diggit-Ezine-Publishing-Be-Careful-of-Filler-Content.html]Ezine Publishing; Be Careful of Filler Content[/url]

There are many additional ways at this type of event to raise more funds than just selling pancakes. Look to add as many fundraising activities as you can such as silent auctions, raffles, and asking for donations.

In computer consulting, the initial sales process is really a pre-sales consultation, not a final sale. Qualifying the client by doing homework about them before-hand will help guarantee that your time and money is not wasted.

No matter what you sell... products, services, or causes... one of the key ingredients to your success will be the attention you give your sales lead follow-up system.

Tags

Links

Digg It - Ezine Publishing; Be Careful of Filler Content

Related Articles: